News & Updates

Show Multimedia Only

Can low-dose atropine prevent myopia?

25 May 2026 by

In the ATOM*3 trial, atropine 0.01% did not prevent the onset of myopia in young children with premyopia (SE** +1.00 to −0.49 dioptres [D]) and low myopia (SE −0.50 to −1.50 D), but there was a trend towards less progression with atropine.

Can low-dose atropine prevent myopia?

25 May 2026

Real-world patients with perianal Crohn’s disease fare well with upadacitinib

25 May 2026

In patients with perianal Crohn’s disease (pCD) treated in routine clinical practice, the use of upadacitinib appears to have a beneficial effect on fistula outcomes, with a more pronounced effect seen for anti-TNF–naïve patients and those with shorter disease duration, according to a multicentre retrospective cohort study.

Real-world patients with perianal Crohn’s disease fare well with upadacitinib

25 May 2026

Low-volume PEG yields high-quality cleansing for bowel preparation in colonoscopy patients

24 May 2026

The use of a 1-litre (L) polyethylene glycol (PEG)-ascorbate in hospitalized adults undergoing elective colonoscopy results in higher rates of high-quality cleansing than a 2L PEG-ascorbate or 4L PEG, reports a study, noting comparable rates of adequate cleansing and high willingness to repeat.

Low-volume PEG yields high-quality cleansing for bowel preparation in colonoscopy patients

24 May 2026

Early antiviral treatment helps reduce risk of long COVID

23 May 2026 by

Individuals with acute COVID-19 who receive prompt antiviral treatment, such as ensitrelvir, nirmatrelvir, or molnupiravir, in the outpatient setting may be less likely to experience post–COVID-19 condition (PCC) compared with those who receive no treatment.

Early antiviral treatment helps reduce risk of long COVID

23 May 2026

Ketamine alleviates suicidal, depressive symptoms

23 May 2026

In patients with acute major depressive episodes (MDE), administering single or repeated intravenous ketamine infusions helps reduce suicidal and depressive symptoms, according to a meta-analysis.

Ketamine alleviates suicidal, depressive symptoms

23 May 2026

Testosterone replacement therapy boosts sexual, physical function after radical prostatectomy

22 May 2026 by

In men with hypogonadism who have undergone radical prostatectomy for low-grade prostate cancer, testosterone replacement therapy (TRT) helps improve sexual and physical function, according to the SPIRIT study.

Testosterone replacement therapy boosts sexual, physical function after radical prostatectomy

22 May 2026

Which medications actually work for chronic migraine?

22 May 2026

Several calcitonin gene-related peptide-targeted therapies show potential efficacy for the treatment of chronic migraine, suggest the results of a systematic review.

Which medications actually work for chronic migraine?

22 May 2026

Novel neuroplastogen for PTSD clears phase 2 trial

22 May 2026

The highly selective, rapid-acting neuroplastogen TSND-201 appears to be efficacious and well tolerated in the treatment of post-traumatic stress disorder (PTSD), according to the results of a phase 2 trial.

Novel neuroplastogen for PTSD clears phase 2 trial

22 May 2026

Guselkumab shows efficacy in perianal fistulizing Crohn’s disease

22 May 2026 by

Treatment with guselkumab resulted in significantly higher rates of combined fistula remission at week 24 in adults with active perianal fistulizing Crohn’s disease (PFCD) compared with placebo, according to the FUZION trial presented at DDW 2026.

Guselkumab shows efficacy in perianal fistulizing Crohn’s disease

22 May 2026

Is 3-month DAPT noninferior to 1-year strategy in CABG patients?

21 May 2026 by

Treatment with dual antiplatelet therapy (DAPT) for 3 months is as good as the 12-month DAPT strategy in saphenous vein graft (SVG) occlusion but is more efficacious in reducing the risk of bleeding among patients undergoing elective coronary artery bypass grafting (CABG), a study has shown.

Is 3-month DAPT noninferior to 1-year strategy in CABG patients?

21 May 2026

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Can low-dose atropine prevent myopia?

Can low-dose atropine prevent myopia?

Real-world patients with perianal Crohn’s disease fare well with upadacitinib

Real-world patients with perianal Crohn’s disease fare well with upadacitinib

Low-volume PEG yields high-quality cleansing for bowel preparation in colonoscopy patients

Low-volume PEG yields high-quality cleansing for bowel preparation in colonoscopy patients

Early antiviral treatment helps reduce risk of long COVID

Early antiviral treatment helps reduce risk of long COVID

Ketamine alleviates suicidal, depressive symptoms

Ketamine alleviates suicidal, depressive symptoms

Testosterone replacement therapy boosts sexual, physical function after radical prostatectomy

Testosterone replacement therapy boosts sexual, physical function after radical prostatectomy

Which medications actually work for chronic migraine?

Which medications actually work for chronic migraine?

Novel neuroplastogen for PTSD clears phase 2 trial

Novel neuroplastogen for PTSD clears phase 2 trial

Guselkumab shows efficacy in perianal fistulizing Crohn’s disease

Guselkumab shows efficacy in perianal fistulizing Crohn’s disease

Is 3-month DAPT noninferior to 1-year strategy in CABG patients?

Is 3-month DAPT noninferior to 1-year strategy in CABG patients?